HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; A pilot study

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Bernal Silva, Sofía ^a   Granados, Julio ^b   Gorodezky, Clara ^c   Aláez, Carmen ^c   Flores Aguilar, Hilario ^c   Cerda Flores, Ricardo M ^a   Guerrero González, Geraldina ^a   Valdez Chapa, Lezmes D ^a   Morales Casas, José ^a   González Guerrero, Juan Francisco ^a   Barrera Saldaña, Hugo A ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

Author keywords

DRB1; HLA class II; HPV; Persistent infection; Susceptibility

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEXICO; OLIGONUCLEOTIDE PROBE; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REINFECTION; UTERINE CERVIX CANCER; VIRAL CLEARANCE;

EID: 84883573829     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-31     Document Type: Article

References (34)

1. The epidemiology of human papillomavirus infections. Baseman JG, Koutsky LA, J Clin Virol 2005 32 Suppl 1 16 S24 15753008
2. Immune responses to human papillomavirus. Stanley M, Vaccine 2006 24 Suppl 1 16 S22 16219398
3. HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions. Peng S, Trimble C, Wu L, Pardoll D, Roden R, Hung CF, Wu TC, Clin Cancer Res 2007 13 8 2479 2487 10.1158/1078-0432.CCR-06- 2916 17438108 (Pubitemid 46698600)
4. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Wank R, Thomssen C, Nature 1991 352 6337 723 725 10.1038/352723a0 1876187 (Pubitemid 21912416)
5. Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Engelmark M, Beskow A, Magnusson J, Erlich H, Gyllensten U, Hum Mol Genet 2004 13 17 1951 1958 10.1093/hmg/ddh201 15238505 (Pubitemid 39214342)
6. Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, de Vries EG, te Meerman GJ, van der Zee AG, J Med Genet 2005 42 8 49 10.1136/jmg.2005.031351 16061555
7. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. Apple RJ, Becker TM, Wheeler CM, Erlich HA, J Natl Cancer Inst 1995 87 6 427 436 10.1093/jnci/87.6. 427 7861462
8. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML, Cancer Epidemiol Biomarkers Prev 2000 9 11 1183 1191 11097225
9. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection. Ferrera A, Olivo A, Alaez C, Melchers WJ, Gorodezky C, Hum Biol 1999 71 3 367 379 10380373 (Pubitemid 29257229)
10. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WD, Int J Cancer 1994 57 4 504 507 10.1002/ijc.2910570411 8181853 (Pubitemid 24173094)
11. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Nawa A, Nishiyama Y, Kobayashi T, Wakahara Y, Okamoto T, Kikkawa F, Suganuma N, Goto S, Kuzuya K, Tomoda Y, Cancer 1995 75 2 518 521 10.1002/1097-0142(19950115)75:2<518::AID- CNCR2820750214>3.0.CO;2-I 7812922
12. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Beskow AH, Josefsson AM, Gyllensten UB, Int J Cancer 2001 93 6 817 822 10.1002/ijc.1412 11519043 (Pubitemid 32756751)
13. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes. Ghaderi M, Wallin KL, Wiklund F, Zake LN, Hallmans G, Lenner P, Dillner J, Sanjeevi CB, Int J Cancer 2002 100 6 698 701 10.1002/ijc.10551 12209609 (Pubitemid 34832981)
14. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Lin P, Koutsky LA, Critchlow CW, Apple RJ, Hawes SE, Hughes JP, Touré P, Dembele A, Kiviat NB, Cancer Epidemiol Biomarkers Prev 2001 10 10 1037 1045 11588129 (Pubitemid 32959150)
15. Human leukocyte antigen class II and cervical cancer risk: a population-based study. Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA, J Infect Dis 2002 186 11 1565 1574 10.1086/345285 12447731 (Pubitemid 35379632)
16. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P, Duncan I, Br J Cancer 2000 82 7 1348 1352 10755413 (Pubitemid 30145357)
17. Biomarkers of Cervical Cancer Risk (BCCR) Study Team: selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. Ades S, Koushik A, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Roger M, Franco EL, Int J Cancer 2008 122 12 2820 2826 10.1002/ijc.23459 18351579 (Pubitemid 351649329)
18. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Chan PK, Cheung JL, Cheung TH, Lin CK, Siu SS, Yu MM, Tang JW, Lo KW, Yim SF, Wong YF, To KF, Ng HK, Chung TK, Gynecol Oncol 2007 105 3 736 741 10.1016/j.ygyno.2007.02.013 17379283 (Pubitemid 46738579)
19. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferencsy AS, Roger M, Coutlee F, Franco EL, J Infect Dis 2007 196 1 82 90 10.1086/518612 17538887 (Pubitemid 46982741)
20. Association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang. Guzalinuer A, Mihrinsa A, Zhang SQ, Li H, Gulishare N, Zhang GQ, Zhonghua Shong Liu Za Zhi 2010 32 7 492 496
21. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, Sherman ME, Alfaro M, Hutchinson ML, Morales J, Lorincz A, Burk RD, Carrington M, Erlich HA, Apple RJ, J Infect Dis 2001 184 10 1310 1314 10.1086/324209 11679920 (Pubitemid 33055576)
22. Different HLA-DR-DQ haplotypes are associated with cervical intraepitelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Sanjeevi CB, Hjelmström P, Hallmans G, Wiklund F, Lenner P, Angström T, Dillner J, Lernmark A, Int J Cancer 1996 68 4 409 414 10.1002/(SICI)1097-0215(19961115)68:4<409::AID-IJC1>3.0.CO;2-4 8945607 (Pubitemid 26414491)
23. HLA and susceptibility to cervical neoplasia. Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ, Hum Immunol 1999 60 337 342 10.1016/S0198-8859(98)00127-X 10363725 (Pubitemid 29239568)
24. Host and viral genetics and risk of cervical cancer: a review. Hildesheim A, Wang SS, Virus Res 2002 89 2 229 240 10.1016/S0168-1702(02)00191-0 12445662 (Pubitemid 35351541)
25. Genetics features of Mexican women predisposing to cáncer of the uterine cérvix. Silva B, Vargas-Alarcón G, Zúñiga- Ramos J, Rodríguez-Reyna TS, Hernández-Martinez B, Osnaya N, Kofman S, Torres-Lobatón A, Granados J, Hum Pathol 1999 30 6 626 628 10.1016/S0046-8177(99)90085-0 10374768 (Pubitemid 29266719)
26. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women. Hernández-Hernández DM, Cerda-Flores RM, Juárez-Cedillo T, Granados-Arriola J, Vargas-Alarcón G, Apresa-García T, Alvarado-Cabrero I, García-Carrancá A, Salcedo-Vargas M, Mohar-Betancourt A, Int J Gynecol Cancer 2009 19 6 1099 1106 10.1111/IGC.0b013e3181a83cf4 19820376
27. HPV-16 and HLA-DRB1 alleles are associated with cervical carcinoma in Mexican Mestizo women. Alaez-Verson C, Berumen-Campos J, Munguía- Saldaña A, Flores-Aguilar H, Guardado-Estrada M, Rodríguez-Gomez A, Gorodezky-Lauferman C, Arch Med Res 2011 42 5 421 425 21911185
28. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Yang YC, Chang TY, Lee YJ, Su TH, Dang CW, Wu CC, Liu HF, Chu CC, Lin M, Hum Immunol 2006 67 4-5 331 340 16720214 (Pubitemid 43729364)
29. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS, Int J Cancer 1996 67 5 595 602 10.1002/(SICI)1097-0215(19960904)67:5<595::AID-IJC1>3.0.CO;2-P 8782644 (Pubitemid 26300972)
30. Influence of HLA-DRB1 alleles on Th1 and Th2 cytokine response to Mycobacterium tuberculosis antigens in pulmonary tuberculosis. Selvaraj P, Nisha Rajeswari D, Jawahar MS, Narayanan PR, Tuberculosis 2007 87 6 544 550 10.1016/j.tube.2007.08.001 17826339 (Pubitemid 47589042)
31. Association study of human leukocyte antigen-DRB1 alleles with rheumatoid arthritis in south Tunisian patients. Ben Hamad M, Mahfoudh N, Marzouk S, Kammoun A, Gaddour L, Hakim F, Fakhfakh F, Bahloul Z, Makni H, Maalej A, Clin Rheumatol 2012 31 6 937 942 10.1007/s10067-012-1954-z 22349877
32. Distribution of HLA class II alleles and haplotypes in Mexican Mestizo population: comparison with other populations. Vargas-Alarcón G, Granados J, Rodríguez-Pérez JM, Parga C, Pérez-Hernández N, Rey D, Zuñiga J, Arnaiz-Villena A, Immunol Invest 2010 39 3 268 283 10.3109/08820131003681151 20380523
33. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ, J Gen Virol 1995 76 Pt 4 1057 1062 9049358
34. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ, J Clin Microbiol 2002 40 3 779 787 10.1128/JCM.40.3.779-787.2002 11880393 (Pubitemid 34208623)